Stereotactic is a medical technique that uses a three-dimensional coordinate system to pinpoint exact locations inside the body, most often the brain. Think of it as a GPS for surgeons and radiation specialists. By mapping internal structures along three axes (left-right, front-back, and up-down), doctors can reach a tiny target deep inside the body without needing to open large areas of tissue. Modern stereotactic systems achieve accuracy within fractions of a millimeter, with some reaching as close as 0.34 mm from the intended target.
How the Coordinate System Works
Every stereotactic procedure starts with imaging, usually an MRI or CT scan, that creates a detailed 3D map of the area being treated. Software then assigns coordinates to every point in that map, just like latitude and longitude on a globe. The surgeon or radiation oncologist identifies the target on the scan, and the system calculates the precise path to reach it while avoiding critical structures along the way.
This concept dates back to 1908, when neurosurgeon Victor Horsley and physiologist Robert Clarke built the first stereotactic frame to study the monkey brain. In 1947, Ernst Spiegel and Henry Wycis adapted the technology for human patients, and by the 1950s multiple stereotactic devices were in use. The core principle has remained the same for over a century: if you can define a target’s position in three-dimensional space, you can reach it with extreme precision.
Frame-Based vs. Frameless Systems
Traditional stereotactic procedures use a rigid metal frame, such as the Leksell frame, that is physically secured to the patient’s skull with small pins. This frame creates fixed reference points that the imaging software can lock onto. The main advantage is precision, especially for small, deep targets. It also allows many procedures to be done under local anesthesia rather than general anesthesia, which matters for elderly or frail patients who may not tolerate being fully sedated. Only about 31% of frame-based brain biopsies require general anesthesia, compared to 97% of frameless procedures.
Frameless systems use adhesive markers (fiducials) or surface-tracking cameras instead of a bolted frame. The patient can have their imaging scan hours or even days before the procedure, making scheduling more flexible and the experience more comfortable. The tradeoff is that frameless approaches may be slightly more prone to drift from hand movement, and studies show a somewhat higher rate of minor post-procedure bleeding, though most of these bleeds cause no symptoms.
Stereotactic Radiosurgery
Despite the name, stereotactic radiosurgery (SRS) involves no scalpel. It delivers a highly focused beam of radiation to a precise target, most commonly a brain tumor, in a single session. The “surgery” is the radiation itself, which is concentrated enough to destroy abnormal tissue while largely sparing the surrounding area. SRS is typically used for tumors smaller than 3 centimeters in the brain or spine.
For tumors outside the brain and spine, the same principle is applied under a different name: stereotactic body radiotherapy, or SBRT. SBRT is delivered over two to five sessions rather than one, and it’s commonly used for lung and liver tumors. In early-stage lung cancer, SBRT produces local tumor control rates above 80% at two years. Each treatment session takes about 30 minutes, covering both patient setup and radiation delivery.
Because the body moves with breathing, SBRT for lung or liver tumors requires methods to account for that motion. Some systems use a breathing-control device that briefly pauses respiration for 15 to 20 seconds at a time. Others track an infrared marker placed on the patient’s abdomen and synchronize the radiation beam to fire only during a specific phase of breathing, usually near the end of an exhale when the body is most still.
Deep Brain Stimulation
Stereotactic guidance is essential for deep brain stimulation (DBS), a treatment for movement disorders like Parkinson’s disease, essential tremor, and dystonia. In DBS, surgeons implant a thin electrode into a specific cluster of brain cells, and the electrode delivers continuous electrical pulses that regulate abnormal signals.
The targets are remarkably small. For Parkinson’s disease, the electrode is typically placed in either the subthalamic nucleus (STN) or the globus pallidus (GPi), and within those structures, the surgeon aims for the motor territory, which is just one subdivision of an already tiny region. For essential tremor, the target is a sliver of the thalamus called the ventralis intermedius (Vim), a structure so narrow it can’t even be distinguished from surrounding tissue on standard MRI scans. Placing an electrode just slightly off-target can produce side effects like tingling or numbness instead of therapeutic benefit, which is why sub-millimeter stereotactic accuracy matters so much in these cases.
Stereotactic Breast Biopsy
Stereotactic techniques aren’t limited to the brain. In breast imaging, a stereotactic biopsy is used to sample suspicious areas, particularly tiny calcium deposits (microcalcifications) that show up on a mammogram but can’t be seen on ultrasound. The mammography machine takes images from two different angles, and a computer triangulates the exact position of the abnormality in three dimensions, guiding a needle to the right spot.
Most stereotactic breast biopsies use a vacuum-assisted needle that can collect multiple tissue samples through a single small skin incision. The amount of tissue collected depends on the needle size. A standard 14-gauge needle retrieves about 40 mg per pass, more than double what an older spring-loaded biopsy gun collects. An 11-gauge needle pulls roughly 100 mg, enough to completely remove lesions smaller than 1 centimeter. The largest commonly used needle, 8-gauge, collects 250 to 310 mg per pass.
Risks and Side Effects
The specific risks depend on which stereotactic procedure you’re having, but the precision of the technique generally keeps complication rates low compared to conventional open surgery.
For stereotactic radiosurgery of the brain, the most significant long-term risk is radiation necrosis, where healthy brain tissue near the treatment site is damaged by the radiation dose. This occurs in roughly 5% to 25% of patients, with about 10% developing symptoms. The most common symptom is headache, reported in about 77% of those affected. Less frequently, patients experience muscle weakness, seizures, or changes in thinking and memory. The underlying cause is believed to be radiation damage to tiny blood vessels, which then leads to secondary injury in surrounding brain tissue.
For stereotactic brain biopsies, the main concern is bleeding at the needle site. Frameless procedures carry a slightly higher rate of detectable post-biopsy bleeding than frame-based ones, though most of these small bleeds are found on follow-up imaging and don’t cause symptoms.
What the Experience Looks Like
If you’re having a frame-based brain procedure, the frame is attached to your head with pins under local anesthesia before imaging begins. This is generally tolerable but can become uncomfortable if worn for an extended period. You’ll then have a CT or MRI scan with the frame in place, and the surgical team uses those images to plan the procedure before heading to the operating room.
With frameless systems, small adhesive markers are placed on your skin, and imaging can happen separately from the procedure itself, sometimes even the day before. This means less time spent in a rigid apparatus and more flexibility in scheduling.
For stereotactic radiation treatments, you won’t feel the radiation itself. Brain treatments typically involve a custom-fitted mask that holds your head completely still. Body treatments may use a molded cushion or breathing management device. Sessions last about 30 minutes, and because the radiation is so precisely targeted, most patients experience fewer side effects than with conventional, broader-field radiation therapy.